Marinus Pharmaceuticals

Marinus Pharmaceuticals Takes Center Stage at AES 2023 with Seven Presentations and Scientific Exhibit

RADNOR, PA — Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a leading pharmaceutical company, has announced that it will present seven abstracts at the upcoming American Epilepsy Society (AES) 2023 Annual Meeting. …

Marinus Pharmaceuticals Takes Center Stage at AES 2023 with Seven Presentations and Scientific Exhibit Read More